@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-BZGR6KDQ-S skos:prefLabel "Purinergic P2Y Receptor Antagonists"@en, "Antagonistes des récepteurs purinergiques P2Y"@fr ; a mesh:Descriptor, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TRVW1W17-7 mesh:allowableQualifier jvr:-T9HQD7ST-J, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-WK5F724J-1, jvr:-D0F21513-5, jvr:-W6SQV79N-S, jvr:-S0CS1X5R-5, jvr:-NFTHND7Q-8, jvr:-R3QWLHRG-V, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-BT300B3G-Q, jvr:-FWD2BGQ0-9, jvr:-R0ZCQ8X6-J, jvr:-XV06LPML-W, jvr:-NKM836P1-M, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-TJHVZCRZ-0, jvr:-CB30NGKB-3, jvr:-NHL3D2X0-S, jvr:-NB0XHT3S-N, jvr:-THHNVC7V-3 ; skos:hiddenLabel "SC 25989C"@en, "Clopidogrel Napadisilate"@en, "Hydrogénosulfate de clopidogrel"@fr, "SC-25990C"@fr, "Clopidogrel Hydrochloride"@en, "Bisulfate de clopidogrel"@fr, "PCR-4099"@fr, "PCR-4099"@en, "Bésylate de clopidogrel"@fr, "Clopidogrel Sandoz"@en, "Chlorhydrate de clopidogrel"@fr, "SC 25990C"@en, "Iscover"@en, "PCR 4099"@en, "SR-25989"@fr, "Clopidogrel Besylate"@en, "Clopidogrel-Mepha"@en, "Clopidogrel Bisulfate"@en, "SC-25989C"@fr, "SR 25989"@en, "Clopidogrel Besilate"@en, "Plavix"@en, "Bésilate de clopidogrel"@fr, "Clopidogrel, (+)(S)-isomer"@en ; skos:altLabel "426O7XWS6Y"@fr, "426O7XWS6Y"@en, "08I79HTP27"@fr, "08I79HTP27"@en, "BL9VGG8BHW"@fr, "BL9VGG8BHW"@en, "A74586SNO7"@en, "A74586SNO7"@fr, "Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate"@fr, "Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate"@en, "113665-84-2 ((+)(S)-isomer))"@fr, "113665-84-2 ((+)(S)-isomer))"@en ; skos:inScheme jvr: ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-GR4BZ8R6-4 ; dc:established "2019-01-01"^^xsd:date ; mesh:pharmacologicalAction jvr:-C10SDGR8-X, jvr:-BZGR6KDQ-S ; dc:created "2018-07-09"^^xsd:date ; skos:prefLabel "Clopidogrel"@en, "Clopidogrel"@fr ; owl:sameAs ; dc:modified "2018-07-09"^^xsd:date ; skos:definition "A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION."@en . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-GR4BZ8R6-4 skos:prefLabel "Ticlopidine"@fr, "Ticlopidine"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-TRVW1W17-7 . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-C10SDGR8-X skos:prefLabel "Antiagrégants plaquettaires"@fr, "Platelet Aggregation Inhibitors"@en ; a mesh:Descriptor, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .